Gene amplification of chromatin remodeling factor SMARCC2 and low protein expression of ACTL6A are unfavorable factors in ovarian high‑grade serous carcinoma.
Article in Oncology Letters (March 2024)
The most recent citing publications are shown below. View all 40 publications that cite this research output on Dimensions.
Article in Oncology Letters (March 2024)
Article in Cell Reports (February 2024)
Article in PLOS ONE (November 2023)